CB
Cambium Biomaterials, Inc.
SEC filingOther Technology · El Segundo, CA
Amount raised$94.4Msold at filing
Total offering$101.4M$7M still open
Investors in the raise33count reported to the SEC
FiledDec 4, 2025first sale Nov 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher PedersonDirector
Brett SchneiderDirector
Francisco GimenezDirector
Tim GardnerExecutive Officer
Stephan HerreraExecutive Officer
Simon WaddingtonExecutive Officer, Director
James GriffinExecutive Officer
Nic MadrenExecutive Officer
Executive officers, directors and promoters as listed on the Form D.